27 February 2025, Thursday
08:30 - 09:00
Registration
09:00 - 09:05
Opening speech
Dr. Katalin Szalóki, Director, AIPM
09:05 - 09:20
Patient story
Zoltán Gazsi, Company Executive, Eisberg Hungary Kft.
09:20 - 09:35
Priorities and opportunities in oncology care –
Dr. Judit Bidló, Deputy State Secretary for Healthcare, Ministry of Interior
09:35 - 09:50
European overview
Prof. Dr. László Csaba Dégi, President, European Cancer Organisation
09:50 - 10:05
The situation of Hungarian cancer patients in European comparison – What do the real-world data say?
Dr. Zoltán Kiss, Associate Professor, University of Pécs
10:05 - 10:20
Presentation
IQVIA
Coffee break
10:50 - 11:05
Cancer therapies: Current Challenges and Future Pathways
Prof. Dr. Csaba Polgár, Outgoing President, Hungarian Society of Oncologists
11:05 – 11:20
New pathways in clinical oncology
Prof. Dr. Judit Moldvay, Board Member, Hungarian Society of Clinical Oncology
11:20 – 12:00
Social awareness – Community and individual responsibility
Roundtable Discussion
Introduction: Ferenc Markovits, Editor–Host, Rákeltérítő podcast – Rákkutatók Association, Telex
moderator: Dr. Janka Kocsis, Senior Manager for Governmental and Corporate Affairs, Bristol Myers Squibb
Zsuzsanna Kapitány, President, Gyógyulj Velünk Association
Krisztina Tóth, Vice President, Egészség Hídja Alliance Against Breast Cancer Association
Icó Tóth, President, Mályvavirág Association
12:00 – 12:40
Long-term interdisciplinary public health collaborations for cancer prevention
Roundtable Discussion
Moderator: Dr. Katalin Szalóki, Director, AIPM
Prof. Dr. Magdolna Dank, Director General, National Institute of Oncology, Medical President, Egészség Hídja Alliance Against Breast Cancer Association
Dr. Magor Papp, Director, Semmelweis Health Development Center
Balázs Rozványi, President, Hungarian Cancer League
Prof. Dr. János Sándor, Director, University of Debrecen, Faculty of General Medicine, Institute of Public Health and Epidemiology, Board Member National Association of Public Health Education and Research Institutions
Dr. György Surján, Director, National Public Health and Pharmaceutical Center, Directorate of Prevention and Epidemiology
Lunch break
13:40 – 14:10
The role of European Union Health Technology Assessment (EU HTA) in the national public financing system – what does it mean in practice?
Roundtable Discussion
moderator: Péter Szegner, Patient Access Enabler & RWD Lead, Roche Hungary Kft.
Dr. Jácinta Juhász, Head of Department, National Public Health and Pharmaceutical Center, Technology Assessment Department
Ákos Karsay, Head of Department, Price Support Department, National Health Insurance Fund Management - TBD
Dr. Anikó Maráz, Associate Professor, University of Szeged, Szent-Györgyi Albert Clinical Center Oncotherapy Clinic
Dr. Balázs Nagy, Associate Professor, Semmelweis University, Health Technology Assessment and Analysis Center
14:10 – 14:50
"Appropriate" end-of-life care
Roundtable Discussion
moderator: Gyöngyi Porkoláb, President of the Board of Trustees, Debrecen Hospice Foundation
Dr. Gábor Benyó, President, Hungarian Hospice-Palliative Association
Dr. Kordáné Dr. Orsolya Horváth, Department Head Physician, Rehabilitation Department, National Institute of Oncology
Dr. Magdolna Kádár, Head of Department, Health Development Policy Department, Ministry of Interior
Miklós Lukács, Vice President, Hungarian Hospice-Palliative Association
Orsolya Pál-Jakab, Development Officer, Ministry of the Interior
Balázs Simonyi, Editor - host Nincs rá szó podcast
Dr. Krisztina Tóth, Medical Director, Hungarian Hospice Foundation
Coffee break
15:20 - 15:50
Changing roles and competencies throughout the entire patient journey
Roundtable Discussion
moderator: Konrád Keresztes, Associate Director, Policy and Communication, MSD
Dr. Zoltán Cserháti, Assistant Professor, operational program leader of the healthcare manager master's program, Semmelweis University Health Services Management Training Center
Dr. Dorottya Mühl, Clinical specialist, Semmelweis University Department of Internal Medicine and Oncology Clinic
Dr. András Süle, Outgoing President, European Association of Hospital Pharmacists
15:50 - 16:30
Innovative solutions in cancer research
Roundtable Discussion
Introduction: Prof. Dr. Csaba Bödör, Professor, Semmelweis University Department of Pathology and Experimental Cancer Research
moderator: Dr. Dalma Sugár, Medical Affairs Director Adriatic-Hungary, AbbVie Kft.
Prof. Dr. Csaba Bödör, Professor, Semmelweis University Department of Pathology and Experimental Cancer Research, Molecular Pathology Center
László Bödör, Executive Director, Genontech Digital Health Solutions Kft.
Bence Horváth, CEO, Spicy Analytics Kft.
Tamás Török, Business Development Manager, Turbine AI
16:30 – 16:35
Closing speech
Dr. Katalin Szalóki, Director, AIPM